EyePoint Pharmaceuticals, Inc. (EYPT)
17.08
-0.74
(-4.15%)
USD |
NASDAQ |
Dec 09, 16:00
17.08
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Total Liabilities (Quarterly): 51.51M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.415B |
| Agios Pharmaceuticals, Inc. | 101.38M |
| Viking Therapeutics, Inc. | 26.38M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 251.70M |
| Shareholders Equity (Quarterly) | 200.18M |
| Debt to Equity Ratio | 0.1162 |
| Current Ratio | 7.181 |
| Net Debt Paydown Yield | 0.00% |